Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Thromboprophylaxis for women undergoing caesarean section.

Kennedy C, O'Dwyer V, O'Kelly S, Farah N, Kennelly M, Turner MJ.

Ir Med J. 2012 Feb;105(2):56-7.

PMID:
22455243
2.

Audit of thromboprophylaxis following caesarean section.

Hiremath VS, Gaffney G.

Ir Med J. 2000 Nov;93(8):234-6.

PMID:
11133055
3.

Venous thromboembolism prophylaxis during and following caesarean section: a survey of clinical practice.

Seeho SK, Nippita TA, Roberts CL, Morris JM, Nassar N.

Aust N Z J Obstet Gynaecol. 2016 Feb;56(1):54-9. doi: 10.1111/ajo.12393. Epub 2015 Aug 21.

PMID:
26293711
4.

Audit of thromboprophylaxis in women undergoing caesarean section.

Khan R, Byrne P.

Ir Med J. 2004 Mar;97(3):72-4.

PMID:
15164686
5.

Thrombin generation post elective caesarean section: effect of low molecular weight heparin.

Ismail SK, Norris L, Muttukrishna S, Higgins JR.

Thromb Res. 2012 Nov;130(5):799-803. doi: 10.1016/j.thromres.2012.01.008. Epub 2012 Feb 24.

PMID:
22365560
6.

Tinzaparin sodium for thrombosis treatment and prevention during pregnancy.

Smith MP, Norris LA, Steer PJ, Savidge GF, Bonnar J.

Am J Obstet Gynecol. 2004 Feb;190(2):495-501.

PMID:
14981396
7.

Thromboprophylaxis for caesarean section--how can uptake and coverage be improved?

Gidiri M, Sant M, Philips K, Lindow SW.

J Obstet Gynaecol. 2004 Jun;24(4):392-4.

PMID:
15203578
8.

Does prolonged thromboprophylaxis improve outcome in patients undergoing surgery?

Rasmussen MS.

Cancer Treat Rev. 2003 Jun;29 Suppl 2:15-7.

PMID:
12887945
9.

Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy.

Ní Ainle F, Wong A, Appleby N, Byrne B, Regan C, Hassan T, Milner M, Sullivan AO, White B, O'Donnell J.

Blood Coagul Fibrinolysis. 2008 Oct;19(7):689-92. doi: 10.1097/MBC.0b013e32830b14ef.

PMID:
18832911
10.

Thromboprophylaxis following caesarean section; hospital protocols are necessary.

Pather S, Sykes P, Davis R, Reid R, Skjellerup N.

N Z Med J. 2001 Jul 27;114(1136):339-40. No abstract available.

PMID:
11548102
11.

Thromboprophylaxis following cesarean delivery: one site prospective pilot study to evaluate the application of a risk score model.

Cavazza S, Rainaldi MP, Adduci A, Palareti G.

Thromb Res. 2012 Jan;129(1):28-31. doi: 10.1016/j.thromres.2011.06.028. Epub 2011 Aug 15.

PMID:
21840574
12.

Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.

Balibrea JL, Altimiras J, Larruzea I, Gómez-Outes A, Martínez-González J, Rocha E; Bemiparin Cooperative Study Group in Surgery for Cancer.

Int J Surg. 2007 Apr;5(2):114-9. Epub 2006 Nov 7.

13.

Thromboprophylaxis practice patterns in two Western Australian teaching hospitals.

Eikelboom JW, Mazzarol A, Quinlan DJ, Beaver R, Williamson J, Yi Q, Hankey GJ; American College of Chest Physicians.

Haematologica. 2004 May;89(5):586-93.

14.

Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.

Beyer-Westendorf J, Lützner J, Donath L, Tittl L, Knoth H, Radke OC, Kuhlisch E, Stange T, Hartmann A, Günther KP, Weiss N, Werth S.

Thromb Haemost. 2013 Jan;109(1):154-63. doi: 10.1160/TH12-07-0510. Epub 2012 Nov 29.

PMID:
23197272
15.

The risk of venous thromboembolism in non-large-joint surgeries.

Muntz JE.

Orthopedics. 2003 Feb;26(2 Suppl):s237-42. Review.

PMID:
12597232
16.

Safety of therapeutic doses of tinzaparin during pregnancy.

Parent F, Deruelle P, Sanchez O, Meyer G, Girard P, Jilwan F, Boyer-Neumann C, Wolf M, Simonneau G.

Gynecol Obstet Invest. 2015;79(4):256-62. doi: 10.1159/000367846. Epub 2015 Apr 21.

PMID:
25896030
17.
19.

Venous thromboembolism occurs frequently in patients undergoing brain tumor surgery despite prophylaxis.

Chan AT, Atiemo A, Diran LK, Licholai GP, McLaren Black P, Creager MA, Goldhaber SZ.

J Thromb Thrombolysis. 1999 Aug;8(2):139-42.

PMID:
10436144
20.

Reduction of venous thromboembolism following prolonged prophylaxis with the low molecular weight heparin Certoparin after endoprothetic joint replacement or osteosynthesis of the lower limb in elderly patients.

Kolb G, Bodamer I, Galster H, Seidlmayer C, Grambach K, Koudela K, Eisele RR, Becker C, Paal V, Spannagel U, Brom J, Weidinger G; Long-term Thromboprophylaxis Study Group.

Thromb Haemost. 2003 Dec;90(6):1100-5.

PMID:
14652643

Supplemental Content

Support Center